Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-12-30 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Please find enclosed disclosure received under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to timely reporting of material events or information by listed companies. The content describes an order issued by a tax authority regarding a tax demand and penalty related to input tax credit issues. It is an announcement of a regulatory or compliance event rather than a financial report, earnings release, or management discussion. The document is relatively short (2966 characters) and serves as a formal notification to stock exchanges about a regulatory order impacting the company. This fits the category of Regulatory Filings (RNS), which is a general category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-12-30 English
Please find enclosed intimation regarding closure of Trading Window.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window for insiders ahead of the announcement of financial results for the quarter and year ending 31st December 2025. It is a compliance and regulatory announcement related to insider trading restrictions, not the financial results themselves or any detailed report. The document length is short (1459 characters) and does not contain any financial data or report content. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories.
2025-12-26 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window for insiders due to the upcoming declaration of financial results for the quarter and year ending 31st December 2025. It is a compliance announcement related to insider trading regulations and does not contain any financial data or results itself. The document is short (1459 characters) and serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-12-26 English
Please find enclosed copies of the Newspaper publication regarding the information on special window for re-lodgement of transfer requests of physical shares.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper publication about a special window for re-lodgement of transfer requests of physical shares. It references compliance with SEBI regulations and includes an enclosure of newspaper copies. The content is primarily an announcement of a regulatory compliance action and publication, not a financial report or detailed analysis. The document length is about 15,000 characters, but the content is an announcement rather than a full report. There is no financial data, earnings information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2025-12-26 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper publication about a special window for re-lodgement of transfer requests of physical shares. It references compliance with SEBI regulations and encloses copies of newspaper publications. The content is primarily an announcement of a regulatory disclosure and includes no financial statements, detailed financial data, or management discussion. The document length is about 15,000 characters but the content is an announcement rather than a full report. There is no indication of it being an annual report, earnings release, or any detailed financial or management report. It fits best as a Regulatory Filing (RNS) because it is a compliance announcement related to SEBI regulations and does not fit other specific categories.
2025-12-26 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details an order issued by the Office of the Deputy Commissioner of State Tax regarding a tax demand for FY 2018-19. The document is a formal notification to stock exchanges about a regulatory or legal matter affecting the company, specifically a tax order and the company's intention to appeal. It does not contain financial statements, earnings data, or detailed management discussion. It is a regulatory announcement about a legal/tax proceeding rather than a full legal proceedings report or financial report. Given the nature of the content and the regulatory disclosure context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.